The investment will go toward finishing a Phase 2a clinical trial for an anti-infective to treat chronic infections in people with CF.
Site Search
Showing 11 - 16 of 16 results
News
|
|
2 min read
Deciding to have a child when you have cystic fibrosis requires a great deal of planning. Fortunately, addressing some key questions can help you navigate the family planning process.
Bill will jump-start rebuilding of the antibiotics pipeline that is vital to stave off a looming pandemic.
News
|
|
3 min read
Managing cystic fibrosis can feel overwhelming at times — but we’re here to help. Learn how to navigate life with CF.
The Cystic Fibrosis Foundation has awarded up to $5.6 million to Microbion Corporation to develop a novel, inhaled antibiotic to treat drug-resistant bacterial infections in people with cystic fibrosis.
News
|
|
2 min read
The U.S. Food and Drug Administration (FDA) has approved TOBI® Podhaler™ (tobramycin inhalation powder), a dry powder formulation of the antibiotic TOBI, to treat lung infections caused by the bacteria Pseudomonas aeruginosa (P. aeruginosa).
News
|
|
1 min read